Relevant bibliographies by topics / Co-occurring symptoms

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Reports

Academic literature on the topic 'Co-occurring symptoms'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Co-occurring symptoms.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Co-occurring symptoms"

1

Roos, Leslie E., Philip A. Fisher, Daniel S. Shaw, Hyoun K. Kim, Jenae M. Neiderhiser, David Reiss, Misake N. Natsuaki, and Leslie D. Leve. "Inherited and environmental influences on a childhood co-occurring symptom phenotype: Evidence from an adoption study." Development and Psychopathology 28, no. 1 (April 8, 2015): 111–25. http://dx.doi.org/10.1017/s0954579415000322.

Full text
Abstract:
AbstractRisk factors for the childhood development of co-occurring internalizing and externalizing symptoms are not well understood, despite a high prevalence and poor clinical outcomes associated with this co-occurring phenotype. We examined inherited and environmental risk factors for co-occurring symptoms in a sample of children adopted at birth and their birth mothers and adoptive mothers (N = 293). Inherited risk factors (i.e., birth mothers' processing speed and internalizing symptoms) and environmental risk factors (i.e., adoptive mothers' processing speed, internalizing symptoms, and uninvolved parenting) were examined as predictors for the development of internalizing-only, externalizing-only, or co-occurring symptoms using structural equation modeling. Results suggested a unique pattern of predictive factors for the co-occurring phenotype, with risk conferred by adoptive mothers' uninvolved parenting, birth mothers' slower processing speed, and the birth mothers' slower processing speed in tandem with adoptive mothers' higher internalizing symptoms. Additional analyses indicated that when co-occurring-symptom children were incorporated into internalizing and externalizing symptom groups, differential risk factors for externalizing and internalizing symptoms emerged. The findings suggest that spurious results may be found when children with co-occurring symptoms are not examined as a unique phenotypic group.
APA, Harvard, Vancouver, ISO, and other styles
2

González-Mercado, Velda J., Jean Lim, Gary Yu, Frank Penedo, Elsa Pedro, Raul Bernabe, Maribel Tirado-Gómez, and Bradley Aouizerat. "Co-Occurrence of Symptoms and Gut Microbiota Composition Before Neoadjuvant Chemotherapy and Radiation Therapy for Rectal Cancer: A Proof of Concept." Biological Research For Nursing 23, no. 3 (February 5, 2021): 513–23. http://dx.doi.org/10.1177/1099800421991656.

Full text
Abstract:
Purpose: To examine a) whether there are significant differences in gut microbial diversity and in the abundance of gut microbial taxa; and b) differences in predicted functional pathways of the gut microbiome between those participants with high co-occurring symptoms and those with low co-occurring symptoms, prior to neoadjuvant chemotherapy and radiation therapy (CRT) for rectal cancer. Methods: Rectal cancer patients (n = 41) provided stool samples for 16 S rRNA gene sequencing and symptom ratings for fatigue, sleep disturbance, and depressive symptoms prior to CRT. Descriptive statistics were computed for symptoms. Gut microbiome data were analyzed using QIIME2, LEfSe, and the R statistical package. Results: Participants with high co-occurring symptoms (n = 19) had significantly higher bacterial abundances of Ezakiella, Clostridium sensu stricto, Porphyromonas, Barnesiella, Coriobacteriales Incertae Sedis, Synergistiaceae, Echerichia-Shigella, and Turicibacter compared to those with low co-occurring symptoms before CRT (n = 22). Biosynthesis pathways for lipopolysaccharide, L-tryptophan, and colanic acid building blocks were enriched in participants with high co-occurring symptoms. Participants with low co-occurring symptoms showed enriched abundances of Enterococcus and Lachnospiraceae, as well as pathways for β-D-glucoronosides, hexuronide/hexuronate, and nicotinate degradation, methanogenesis, and L-lysine biosynthesis. Conclusion: A number of bacterial taxa and predicted functional pathways were differentially abundant in patients with high co-occurring symptoms compared to those with low co-occurring symptoms before CRT for rectal cancer. Detailed examination of bacterial taxa and pathways mediating co-occurring symptoms is warranted.
APA, Harvard, Vancouver, ISO, and other styles
3

González-Mercado, Velda J., Wendy A. Henderson, Anujit Sarkar, Jean Lim, Leorey N. Saligan, Lawrence Berk, Larry Dishaw, et al. "Changes in Gut Microbiome Associated With Co-Occurring Symptoms Development During Chemo-Radiation for Rectal Cancer: A Proof of Concept Study." Biological Research For Nursing 23, no. 1 (July 23, 2020): 31–41. http://dx.doi.org/10.1177/1099800420942830.

Full text
Abstract:
Purpose: To examine a) whether there are significant differences in the severity of symptoms of fatigue, sleep disturbance, or depression between patients with rectal cancer who develop co-occurring symptoms and those with no symptoms before and at the end of chemotherapy and radiation therapy (CRT); b) differences in gut microbial diversity between those with co-occurring symptoms and those with no symptoms; and c) whether before-treatment diversity measurements and taxa abundances can predict co-occurrence of symptoms. Methods: Stool samples and symptom ratings were collected from 31 patients with rectal cancer prior to and at the end of (24–28 treatments) CRT. Descriptive statistics were computed and the Mann-Whitney U test was performed for symptoms. Gut microbiome data were analyzed using R’s vegan package software. Results: Participants with co-occurring symptoms reported greater severity of fatigue at the end of CRT than those with no symptoms. Bacteroides and Blautia2 abundances differed between participants with co-occurring symptoms and those with no symptoms. Our random forest classification (unsupervised learning algorithm) predicted participants who developed co-occurring symptoms with 74% accuracy, using specific phylum, family, and genera abundances as predictors. Conclusion: Our preliminary results point to an association between the gut microbiota and co-occurring symptoms in rectal cancer patients and serves as a first step in potential identification of a microbiota-based classifier.
APA, Harvard, Vancouver, ISO, and other styles
4

L. McCallum, Stacey, Antonina A. Mikocka-Walus, Hannah Keage, Owen Churches, and Jane Andrews. "A novel treatment resource for co-occurring symptoms." Advances in Dual Diagnosis 6, no. 4 (November 18, 2013): 155–67. http://dx.doi.org/10.1108/add-08-2013-0018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

McCauley, James B., Rebecca Elias, and Catherine Lord. "Trajectories of co-occurring psychopathology symptoms in autism from late childhood to adulthood." Development and Psychopathology 32, no. 4 (July 17, 2020): 1287–302. http://dx.doi.org/10.1017/s0954579420000826.

Full text
Abstract:
AbstractGiven high rates of co-occurring conditions in youth and adults with autism spectrum disorder (ASD), it is critical to examine the developmental trajectories of these symptoms of psychopathology. Using data from a cohort of participants (n = 194), most of whom were first assessed for ASD in very early childhood, we investigated the trajectories of co-occurring depressive, anxiety, and attention-deficit hyperactivity disorder (ADHD) symptoms from late childhood to adulthood. Additionally, childhood predictors and adult outcomes associated with these symptom trajectories were examined. Using group-based trajectory modeling, we found two distinct classes of individuals exhibiting each of these co-occurring symptom patterns: one class exhibited fairly low symptoms across time, and one class with elevated symptoms with varied fluctuation across time (ADHD symptoms starting high but decreasing, anxiety symptoms high and stable, and depressive symptoms fluctuating but peaking at clinically significant levels in young adulthood). All high trajectory classes were associated with age 9 adaptive skills; verbal IQ predicted higher anxiety and depressive symptom classes. After accounting for verbal IQ, all high symptom trajectory classes were negative predictors of objective adult outcomes. These findings call for wide-ranging considerations of the needs of individuals across ability levels, autism symptoms, and behavioral and emotional challenges.
APA, Harvard, Vancouver, ISO, and other styles
6

Mezulis, Amy, Ann Vander Stoep, Andrea L. Stone, and Elizabeth McCauley. "A Latent Class Analysis of Depressive and Externalizing Symptoms in Nonreferred Adolescents." Journal of Emotional and Behavioral Disorders 19, no. 4 (September 14, 2010): 247–56. http://dx.doi.org/10.1177/1063426610377763.

Full text
Abstract:
Both depressive and externalizing symptoms are common in adolescence and often co-occur. The purpose of this study was to examine whether adolescents’ patterns of depressive and externalizing symptoms can be differentiated into discrete classes and whether these classes are best distinguished by the number or type of symptoms. We examined whether there are naturally occurring discrete classes of adolescents characterized by depressive symptoms only, externalizing symptoms only, or co-occurring depressive and externalizing symptoms. In this study, 2,187 nonreferred, public school sixth graders self-reported depressive and externalizing symptoms, and these symptoms were analyzed with latent class analysis. Six latent classes of depressive and externalizing symptoms were identified; classes differed primarily by the number, not type, of symptoms endorsed. Youth with elevations in one symptom type were likely to have elevations in the other symptom type. Approximately 5% of adolescents displayed clinically significant elevations in both depressive and externalizing symptoms. Implications for understanding the co-occurrence of depressive and externalizing symptoms in adolescence are discussed.
APA, Harvard, Vancouver, ISO, and other styles
7

Whisenant, Meagan, Bob Wong, Sandra A. Mitchell, Susan L. Beck, and Kathi Mooney. "Symptom Trajectories Are Associated With Co-occurring Symptoms During Chemotherapy for Breast Cancer." Journal of Pain and Symptom Management 57, no. 2 (February 2019): 183–89. http://dx.doi.org/10.1016/j.jpainsymman.2018.11.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Newland, Pamela, Louise Flick, Hong Xian, and Florian P. Thomas. "Symptom Co-occurrences Associated with Smoking in Individuals with Relapsing-Remitting Multiple Sclerosis." International Journal of MS Care 18, no. 4 (July 1, 2016): 163–68. http://dx.doi.org/10.7224/1537-2073.2014-028.

Full text
Abstract:
Background: The impact of tobacco on the multiple sclerosis (MS) disease process and symptoms is complex and not clearly understood. Tobacco may be used to self-treat some symptoms but also seems to intensify others. Studies to date have not characterized co-occurring symptoms (symptom patterns) and their association with tobacco use. Methods: This study describes tobacco use in patients with relapsing-remitting MS and associated symptoms and symptom co-occurrences. In this cross-sectional study, 101 participants with an average age of 43 years completed a survey adapted from the Behavioral Risk Factor Surveillance System and the revised MS-Related Symptom Checklist. Data reduction was performed using factor analysis on the 43 items of the checklist, and linear regression was used to detect associations between symptom clusters (factors) and smoking. Results: Using the factor analysis result, the linear regression analysis found that tobacco use is positively associated with co-occurring symptoms and symptoms of factor 1: Mental/Emotional (anxiety, loneliness, depression, and difficulty sleeping) and factor 4: Neuro/Autonomic (urinary). Conclusions: Smoking is associated with patterns of symptoms. The study of MS and tobacco use over time will allow determination of the temporal pattern of tobacco use and MS symptoms.
APA, Harvard, Vancouver, ISO, and other styles
9

Kasckow, John W., and Sidney Zisook. "Co-Occurring Depressive Symptoms in the Older Patient with Schizophrenia." Drugs & Aging 25, no. 8 (2008): 631–47. http://dx.doi.org/10.2165/00002512-200825080-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

van Donkelaar, Marjolein, Celeste Figaroa, Ellen Verhoef, Simon Fisher, Dheeraj Rai, and Beate St Pourcain. "T15EXPLORING THE GENETIC ARCHITECTURE OF CO-OCCURRING SYMPTOMS IN AUTISM." European Neuropsychopharmacology 29 (October 2019): S227. http://dx.doi.org/10.1016/j.euroneuro.2019.08.214.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Co-occurring symptoms"

1

Steinberg, Elizabeth Anne. "ADHD and Co-occurring Psychological Symptoms: Emotion Regulation and Parenting as Potential Moderators." Diss., Temple University Libraries, 2015. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/346682.

Full text
Abstract:
Psychology
Ph.D.
A multitude of research demonstrates that ADHD is associated with negative psychological correlates and outcomes among children, such as academic difficulties and peer relationship problems. Youth with ADHD also experience high rates of comorbidity or co-occurring conditions, including mood, anxiety, oppositional defiant, and conduct disorders. However, few studies have investigated the development of co-occurring psychological symptoms among youth with ADHD over time and across different developmental periods. Shared risk factors likely contribute to the development of ODD, CD, anxiety, and depression among youth with ADHD. Emotion regulation and parenting style may confer risk or resilience for the development of co-occurring symptoms, but research is wanting. The current study examined an existing sample of youth who were recruited at age 10-12 and were followed at age 12-14 and 16. Analyses aimed to (a) identify subgroups of youth varying in type and levels of ADHD and co-occurring symptoms at three different time points using latent class analyses, (b) examine stability of membership and transitions to classes that differ in levels of ADHD and co-occurring symptoms using latent transition analyses, and (c) investigate emotion regulation and parenting style as predictors of stability and transitions among classes. Results revealed different patterns of ADHD and co-occurring symptoms, including a Low Symptoms class at each time point. Classes of youth with ADHD+Externalizing problems and ADHD+Internalizing problems emerged at ages 10-12 and 12-14. At age 16, two classes with qualitatively and quantitatively different externalizing and internalizing symptoms were identified. Latent transition analyses revealed transitions into the Low Symptoms class from each time point, but also stability and transitions to other symptomatic classes. Predictor analyses indicated that emotion regulation and parenting style were associated with transitions among and stability within classes, but findings were dependent on whether classes were defined primarily by co-occurring externalizing or internalizing symptoms. Results of the present study indicate that children with ADHD are likely to exhibit a range of psychological symptoms, but the frequency and quality of co-occurring symptoms may change over time. Emotion regulation and parenting may be potential targets for enhanced interventions among youth with ADHD with and without co-occurring symptoms.
Temple University--Theses
APA, Harvard, Vancouver, ISO, and other styles
2

Swaminathan, Sindhia. "Relationships between symptoms and adaptive functioning in clinic-referred adolescents: Patterns of internalizing, externalizing, and co-occurring symptoms." Bowling Green State University / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=bgsu1457534784.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lövenhag, Sara. "Substance Use in Swedish Adolescents : The Importance of Co-occurring Psychiatric Symptoms and Psychosocial Risk." Doctoral thesis, Uppsala universitet, Institutionen för neurovetenskap, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-251558.

Full text
Abstract:
Aims: Study I: Identify substance use disorders (SUDs), psychiatric disorders, and psychosocial risk (PSR) in adolescence, to predict SUD after 5 years in 147 adolescents who sought treatment at a misuse-clinic. Study II: Identify alcohol risk use (ARU) and its association with psychiatric symptoms and PSR in 960 adolescents who sought treatment in general psychiatric care. Study III: Examine the effect of antisocial behavior (ASB) on the association between inattention, hyperactivity, impulsivity, and alcohol use in 3,864 adolescent students. Study IV: Examine the veracity of drug use reports comparing responses in questionnaires, in-depth interview, and hair analysis in 200 adolescent students. Results: Study I: SUDs in adolescence persisted into early adulthood. Predictors for SUD: girls who had mothers with alcohol use disorder, victimization, criminality, SUD, or SUD treatment. Study II: Prevalence of ARU was 20%. ARU increased with the number of psychiatric symptom domains. Probability of psychiatric symptoms increased with ARU. Most ARU was found in: ASB and sexual abuse. Most common in ARU: symptoms of ADHD, depression, and anxiety. Study III: ASB reduced association between inattention, hyperactivity, impulsivity, and alcohol use for boys, and hyperactivity and impulsivity for girls. Girls’ inattention continued to affect alcohol use despite the presence of ASB. Study IV: Twice as many participants reported drug use in interviews compared to questionnaires. Questionnaires and hair-analysis showed low sensitivity and high specificity. Responses from participants in less privileged socioeconomic circumstances were less reliable. Conclusions: Study I: Treatment-as-usual experienced difficulties preventing the persistence of SUD. Participants’ comorbidity and PSR must be attended to. Study II: ARU in general psychiatric care is prevalent and associated with other psychiatric symptoms, and all symptoms must be attended to simultaneously. Study III: ASB should be screened for when symptoms of ADHD are present. Inattention in girls might require special attention to prevent alcohol use. Study IV: Interviews might be an alternative to questionnaires. Hair analysis was less useful in this population, but a physical measure might function as a pipeline procedure. Responses from participants in less privileged circumstances might be interpreted with caution.
APA, Harvard, Vancouver, ISO, and other styles
4

Hogansen, Jennifer Malia. "Trajectories of co-occurring aggressive and depressive symptoms in children : prediction from child and family characteristics /." view abstract or download file of text, 2004. http://wwwlib.umi.com/cr/uoregon/fullcit?p3136417.

Full text
Abstract:
Thesis (Ph. D.)--University of Oregon, 2004.
Typescript. Includes vita and abstract. Includes bibliographical references (leaves 118-124). Also available for download via the World Wide Web; free to University of Oregon users.
APA, Harvard, Vancouver, ISO, and other styles
5

Evans, Miranda. "The Role of Individual Difference in Predicting Psychopathology Following Peer Victimization." ScholarWorks@UNO, 2019. https://scholarworks.uno.edu/td/2691.

Full text
Abstract:
eer victimization is a common experience that is associated with later psychopathology. However, there is inconsistency in the strength and statistical significance of this effect. The current study used two methods to try to understand this inconsistency. First, co-occurring internalizing and externalizing symptoms were considered dimensionally. Second, the present study considered temperament as a potential moderator to explain the multifinality of outcomes that occur following peer victimization. A community sample (N = 387; 52% female) of early adolescents (11-15) from a longitudinal study of risk and resilience factors for psychopathology was utilized to test hypotheses. Cross-lagged examinations between victimization and psychopathology were examined, including the moderating effect of temperament. No longitudinal relationship between victimization and psychopathology was found. A significant interaction between victimization and effortful control predicted externalizing and co-occurring symptoms. Future researchers should consider improving the measurement of victimization and temperament to get a better understanding of the effect.
APA, Harvard, Vancouver, ISO, and other styles
6

Lanza, Haydee Isabella. "Co-occurring Oppositional Defiant and Depressive Symptoms: Emotion Dysregulation as an Underlying Process and Developmental Patterns across Middle Childhood." Diss., Temple University Libraries, 2010. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/73390.

Full text
Abstract:
Psychology
Ph.D.
Although there has been a recent surge in research examining comorbidity between externalizing and internalizing disorders in childhood, relatively less work has examined relations between specific externalizing conditions (i.e., oppositional defiant disorder (ODD) symptoms) and their co-occurrence with specific internalizing conditions (i.e., depressive symptoms). Furthermore, little empirical work has evaluated potential underlying processes, such as emotion dysregulation, which may explain relations between co-occurring ODD and depressive symptoms. There is also a paucity of research examining developmental patterns of co-occurring ODD and depressive symptoms. In the present study, I used latent class and latent transition analyses to (a) identify groups of children based on ODD and depressive symptom levels, (b) determine whether emotion dysregulation predicted co-occurring ODD and depressive symptoms, and (c) examine developmental patterns of change and continuity in groups across middle childhood within a community-based sample. Children were characterized by three latent classes based on ODD and depressive symptom severity: a group with very low levels of ODD or depressive symptoms, an ODD-only group with low levels of symptoms, and a co-occurring ODD and depressive symptom group with moderate levels of ODD and low levels of depressive symptoms. Furthermore, emotion dysregulation predicted to the class with moderate levels of ODD and low levels of depressive symptoms, although prediction from emotion dysregulation to class membership depended on the methodology used to index emotion dysregulation. Results of the LTA analyses suggested that symptom severity was relatively stable across middle childhood, with little evidence of changes in developmental patterns of ODD and depressive symptoms. Overall, the results of this study provide an important foundation for more sophisticated empirical inquiry regarding co-occurring ODD and depressive symptoms in childhood and potential processes that may explain their onset and development.
Temple University--Theses
APA, Harvard, Vancouver, ISO, and other styles
7

Sonnby, Karin. "Co-occurring Symptoms of Attention Deficit Hyperactivity Disorder and Depression : Sex, Aetiology, Help-Seeking and Assessment." Doctoral thesis, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-219389.

Full text
Abstract:
The general aim of the thesis was to contribute to the knowledge about co-occurring symptoms of ADHD and depression in adolescence, focusing on sex differences, as well as aetiology, help-seeking and assessment. Studies I–III used epidemiological samples of self-reports from all students in Västmanland aged 15–16 and 17–18 years. Study I investigated the prevalence of co-occurring symptoms of ADHD and depression, as well as associations between co-occurring symptoms of ADHD and depression and one environmental stress factor; experience of sexual abuse. Study II examined associations between one biological factor—a polymorphism in TFAP-2β—and co-occurring symptoms of ADHD with andco-occurringsymptoms of depression. Study III investigated the association between the parent–adolescent relationship and seeking help from specialized mental health services in relation to symptoms of ADHD and/or depression. Study IV was a clinical study among adolescent psychiatric patients that compared self-reported ADHD symptoms via the Adult ADHD Self-Report Scale–Adolescent version (ASRS-A) and the Adult ADHD Self-Report Scale–Adolescent–Screening version (ASRS-A-S) with an ADHD diagnosis determined by the gold-standard method; the Kiddie Schedule of Affective Disorders and Schizophrenia diagnostic interview. Studies I–III showed that the phenotype of co-occurring symptoms of ADHD and depression is frequent, with a distinct preponderance among girls. Approximately 50% of both boys and girls with co-occurring symptoms of ADHD and depression had also experienced sexual abuse, indicating that this is a group with multiple risk factors for long-term impaired mental health. Results also support biological sex differences because girls with symptoms of ADHD and a common polymorphism of TFAP-2β (absence of a 9 repeat) reported more symptoms of depression, but boys did not. Further, only 5% of the adolescents with symptoms of ADHD and/or depression sought help from specialized mental health services. The co-occurrence of symptoms of ADHD and depression was a stronger predictor of help-seeking than all other psychosocial factors investigated, including secure attachment cognitions styles to parents. Among help-seeking girls, co-occurring symptoms of ADHD and depression were more common than symptoms of ADHD without co-occurring symptoms of depression. The ASRS-A/ASRS-A-S showed promising psychometric properties for further validation in adolescentsresults as a screening tool for use in adolescents.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Co-occurring symptoms"

1

Gilmore, Amanda K., Kaitlin E. Bountress, Emma L. Barrett, Sudie E. Back, and Kathleen T. Brady. PTSD and Co-Occurring Substance Use Disorders. Edited by Charles B. Nemeroff and Charles R. Marmar. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190259440.003.0028.

Full text
Abstract:
Post-traumatic stress disorder (PTSD) commonly co-occurs with a number of psychiatric disorders including depression, other anxiety disorders, and medical comorbidity. Substance use disorders (SUD) are among the most commonly co-occurring disorders with PTSD and can complicate the course of illness and treatment. This chapter will discuss co-occurring PTSD and SUD (PTSD/SUD) in terms of epidemiology, theoretical underpinnings, and clinical implications. This chapter also describes clinical assessments for PTSD/SUD and provides a list of potential assessments for use in clinical settings. Further, behavioral and pharmacological evidence-based treatments are described that can be effective in reducing both SUD and PTSD symptoms among individuals with PTSD/SUD. Future work that would help move the field forward regarding etiology and treatment of PTSD/SUD are discussed.
APA, Harvard, Vancouver, ISO, and other styles
2

White, Susan W., Brenna B. Maddox, and Carla A. Mazefsky, eds. The Oxford Handbook of Autism and Co-Occurring Psychiatric Conditions. Oxford University Press, 2020. http://dx.doi.org/10.1093/oxfordhb/9780190910761.001.0001.

Full text
Abstract:
People with autism spectrum disorder (ASD) are often diagnosed, and treated for, co-occurring mental health disorders. Co-occurring problems are, in fact, a primary reason for referral and treatment-seeking. Research on comorbidity and its management in youth and adults with ASD has expanded at a rapid rate over the last decade. This is the first comprehensive volume on the topic of co-occurring psychiatric conditions and symptoms in ASD. In this Handbook, internationally recognized clinical scientists synthesize the research on assessment and evidence-based treatment for a broad range of conditions as they present in ASD, from childhood through adulthood. In addition to coverage of formal diagnoses that frequently present in ASD (e.g., mood and anxiety disorders), common behavioural concerns (e.g., psychosexual and sleep problems) are also addressed. Each chapter summarizes the condition or disorder as it presents in ASD, and presents the extant research on its prevalence, developmental course, etiology, and assessment and diagnosis in the context of ASD. Each chapter also includes a summary of evidence-based treatment approaches or current best practices for intervention, as well as a case example to demonstrate application. Chapters are also included to synthesize broader issues related to co-occurring psychiatric conditions in ASD, including a historical overview and conceptual framework for co-occurring conditions in ASD, crisis management, and psychopharmacology. In sum, this handbook is comprehensive compilation of the current evidence-base and recommendations for future research to inform clinical practice related to co-occurring psychiatric conditions and symptoms in ASD.
APA, Harvard, Vancouver, ISO, and other styles
3

Ziegler, Penelope P. Pain and Addiction in Patients with Co-Occurring Psychiatric Disorders (DRAFT). Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190265366.003.0024.

Full text
Abstract:
Addressed equally to psychiatrists and to primary care providers, this chapter is intended to explore non–substance use disorder psychiatric diagnoses as they impact the perception of pain and the treatment of substance use disorders. A screening checklist emphasizing basic principles of psychiatric history-taking is provided to help identify the patient’s requirements. The author reviews the classes of psychiatric diagnoses most likely to be present in the pain/addiction and other comorbidly-ill patients, and reviews suicide risks. Similarly, the classes of medications employed in psychiatry and their capacity for alleviation or aggravation of substance use disorders are reviewed, with notations of drug–drug interactions. A final section addresses the role of emotions and psychiatric symptoms in the perception and management of pain.
APA, Harvard, Vancouver, ISO, and other styles
4

Skipper, Cathy, and Florian Birkmayer. The Role of Aromatherapy in the Treatment of Substance Use and Co-Occurring Disorders. Edited by Shahla J. Modir and George E. Muñoz. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190275334.003.0024.

Full text
Abstract:
Aromatherapy can be an important tool in the treatment of substance abuse and co-occurring disorders. When used by trained specialists, essential oils are safe, simple, and effective both in alleviating symptoms as well as helping increase self-awareness and transform consciousness. Olfaction is a powerful sensory modality, and olfactory receptors have been found in nearly every tissue of the body and parts of the Central Nervous System (CNS) relevant to addiction and motivation. Essential oils are widely used to support and alleviate nervous symptom disorders such as those triggered by addiction (i.e., anxiety, sleep problems, panic attacks, depression, stress etc.). The available scientific literature supports the traditional uses of the most common essential oils in this domain and is encouraging for the continued development of these powerful plants extracts for addiction support.
APA, Harvard, Vancouver, ISO, and other styles
5

Vázquez, Gustavo H., Alberto Forte, Sebastián Camino, Leonardo Tondo, and Ross J. Baldessarini. Treatment implications for bipolar disorder co-occurring with anxiety syndromes and substance abuse. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198748625.003.0017.

Full text
Abstract:
Anxiety symptoms and syndromes affect approximately half of both types I and II bipolar disorder (BD) patients at some time, more in women than men. Reported prevalence has ranked: generalized anxiety ≥ phobias ≥ panic ≥ post-traumatic stress syndrome ≥ obsessive–compulsive syndrome. BD associated with anxiety disorders is less responsive to mood-stabilizing treatments, with greater disability, substance abuse, and possibly suicidal risk. Emerging treatments for anxiety in BD patients include lurasidone, olanzapine, quetiapine, valproate, and psychotherapies, whereas the efficacy and safety of standard anxiolytics and antidepressants are not established. Abuse of alcohol, cannabis, stimulants, and opioids, alone or in combinations, also affects about half of BD patients at some time—more men than women and possibly somewhat more in type I than II. Substance abuse greatly complicates clinical care, contributing to erratic treatment-adherence, adverse outcomes, disability, increased risk of suicide or accidental death, and increased costs of care and from disability.
APA, Harvard, Vancouver, ISO, and other styles
6

Guerdjikova, Anna I., Paul E. Keck, and Susan L. McElroy. The impact of psychiatric co-morbidity in the treatment of bipolar disorder: focus on co-occurring attention deficit hyperactivity disorder and eating disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198748625.003.0018.

Full text
Abstract:
Bipolar disorder (BD) commonly co-occurs with attention deficit hyperactivity disorder (ADHD) and eating disorders (EDs) in adolescents and in adults. The aim of this chapter is to summarize the available data regarding prevalence, clinical presentation, and psychological and pharmacological treatment of such complicated cases. Results of randomized controlled and open-label trials and case reports are reviewed. The main therapeutic goal when treating BD co-morbid with ADHD or ED is selecting a treatment strategy effective in the management of both syndromes, or at the minimum, selecting one that treats one syndrome without exacerbating the other. Controlled data are scarce. Various classes of medications, including stimulants, atomoxetine, bupropion, and wakefulness-provoking agents, might hold promise as adjunctive medication in improving ADHD symptoms in euthymic BD patients. The specificities of the ED, namely the predominance of undereating or overeating, need to be considered when selecting agents in the treatment of BD co-morbid with EDs.
APA, Harvard, Vancouver, ISO, and other styles
7

Capaldi, Deborah M., and Hyoun K. Kim. Comorbidity of Depression and Conduct Disorder. Edited by C. Steven Richards and Michael W. O'Hara. Oxford University Press, 2014. http://dx.doi.org/10.1093/oxfordhb/9780199797004.013.015.

Full text
Abstract:
Both depression and conduct disorders are relatively prevalent and are related to poor long-term outcomes. Despite being characterized by very different symptoms, it is well established that these two disorders co-occur at higher rates than expected by chance, resulting in poorer adjustment for the individual than would result from either problem alone. The termcomorbidityis usually reserved to refer to the association of diagnosed disorders, whereasco-occurrencerefers more broadly to the association of levels of symptoms of conduct problems and depression, which are usually calculated with means or possibly symptoms counts. In the past two decades, researchers have focused particularly on the following issues regarding the comorbidity of depression and conduct disorder: (1) possible causal associations of the two problem behaviors (i.e., do depressive disorders tend to onset after conduct disorders or vice versa); (2) theory regarding causes of the association (i.e., common versus unique risk factors for these two problem behaviors); (3) changes across development (i.e., with age); (4) risks from diagnosed disorders versus symptoms that do not reach diagnostic criteria; (5) outcomes or prognosis (e.g., are outcomes more severe for co-occurring problems than for either problem alone, are there distinct patterns of outcomes associated with co-occurring problems). Within each of these areas there is considerable interest in moderation of effects by gender or gender similarities and differences. This chapter reviews findings pertaining to these issues and presents suggestions for future research. In addition, assessment approaches and clinical implications are discussed.
APA, Harvard, Vancouver, ISO, and other styles
8

Fertuck, Eric A., Megan S. Chesin, and Brian Johnston. Borderline Personality Disorder and Mood Disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199997510.003.0011.

Full text
Abstract:
Borderline personality disorder (BPD) and mood disorder (MD) can be difficult to differentiate from each other due to several overlapping clinical features. Among BPD symptoms, chronic dysphoria can be mistaken for major depression, while affective instability may be confused with the depressed and elevated mood episodes of bipolar disorder (BD). Conversely, in those with BPD, co-occurring MDs can be difficult to rigorously assess and treat. Even though there is moderate to high co-occurrence between these conditions, BPD and MDs have distinct facets of impulsivity, affective instability, and mood symptoms. Furthermore, BPD, MD, and their co-occurrence predict courses of illness, prognosis, treatment outcomes, and suicide risk. Consequently, thorough assessment and differential diagnosis of these conditions should inform treatment planning and clinical management in both BPD and MD.
APA, Harvard, Vancouver, ISO, and other styles
9

Bateman, Anthony W., and Roy Krawitz. Borderline personality disorder. Oxford University Press, 2015. http://dx.doi.org/10.1093/med:psych/9780199644209.003.0001.

Full text
Abstract:
Chapter 1 outlines borderline personality disorder (BPD), the history of BPD, its epidemiology, diagnosis and a thorough discussion of the elements of the DSM-IV-TR diagnostic criteria for BPD, and explores individual factors to help understand a person’s BPD (biological vulnerability theory, emotional sensitivity, mentalizing vulnerability, Beck’s core schemas, dichotomous (all or nothing) thinking, fluctuating competence, active passivity), and co-occurring conditions (depression, bipolar disorder, psychotic symptoms, dissociation, personality disorders). The chapter also discusses etiology (biological factors, psychological factors, nature and nurture, sociocultural factors), self-harm, prognosis, and psychosocial treatment outcome studies.
APA, Harvard, Vancouver, ISO, and other styles
10

Back, Sudie E., Edna B. Foa, Therese K. Killeen, Katherine L. Mills, Maree Teesson, Bonnie Dansky Cotton, Kathleen M. Carroll, and Kathleen T. Brady. Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE). Oxford University Press, 2015. http://dx.doi.org/10.1093/med:psych/9780199334513.001.0001.

Full text
Abstract:
Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) is a an integrated treatment cognitive-behavioral psychotherapy program designed for patients who have posttraumatic stress disorder (PTSD) and a co-occurring alcohol or drug use disorder. COPE represents an integration of two evidence-based treatments: Prolonged Exposure (PE) therapy for PTSD and Relapse Prevention for substance use disorders, where both the PTSD and substance use disorder are addressed concurrently in therapy by the same clinician, and patients can experience substantial reductions in both PTSD symptoms and substance use severity. The program includes information about how PTSD symptoms and substance use interact with one another; information about the most common reactions to trauma; techniques to help the patient manage cravings and thoughts about using alcohol or drugs; coping skills to help the patient prevent relapse to substances; a breathing retraining relaxation exercise; and in vivo (real life) and imaginal exposures to target the patient's PTSD symptoms.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Co-occurring symptoms"

1

Bramness, Jørgen G., and Johan Franck. "Substance-Induced Psychotic Symptoms." In Co-occurring Addictive and Psychiatric Disorders, 87–102. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-45375-5_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schirmbeck, Frederike, and Antonio Tundo. "Cognitive Behavioural Therapy for Co-occurring Obsessive-Compulsive Symptoms." In Obsessive-Compulsive Symptoms in Schizophrenia, 203–17. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-12952-5_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wolf, Jonathan, Jeannine B. Mielke, and Johanna M. Wolf. "Mild TBI and Co-Occurring PTSD Symptoms in Service Member Populations." In Traumatic Brain Injury, 225–38. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-22436-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Campbell, Justin S., Jeffrey H. Greenberg, and Jennifer M. Weil. "Confronting Mild TBI and Co-occurring Post-traumatic Stress Disorder Symptoms in Combat Deployed Service Members." In Traumatic Brain Injury, 205–22. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-0-387-87887-4_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hersh, Richard G., Eve Caligor, and Frank E. Yeomans. "Transference-Focused Psychotherapy (TFP) Principles in the Management of Co-occurring Medical and Personality Disorder Symptoms." In Fundamentals of Transference-Focused Psychotherapy, 187–230. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-44091-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Stoller, Kenneth B. "Psychiatric Co-Occurring Disorders." In ASAM Handbook of Addiction Medicine, 349–78. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780197506172.003.0015.

Full text
Abstract:
Substance use disorders commonly co-occur with psychiatric disorders. Psychiatric illnesses are associated with substance use disorders. Recognition of psychiatric symptoms, especially suicidal ideation, is essential. Factors such as substance use or withdrawal, related psychosocial stressors, and co-occurring somatic health problems complicate the diagnostic process. Addressing psychiatric symptoms is essential to optimize treatment of substance use disorders. Medications can help but may be unnecessary once substance use is stabilized. Other approaches include counseling, psychotherapy, case coordination, and inpatient/residential care. The affective disorders, especially bipolar disorder, are associated with substance use disorders. Depression is common and often improves with addiction treatment. For those who do not improve, antidepressant medication or psychotherapy may help. Anxiety disorders and post-traumatic stress disorder are associated with substance use disorders. If left unaddressed, persistent worry and anxiety worsen treatment outcomes. Although there are effective pharmacotherapies, psychotherapeutic approaches are a mainstay of treatment. Schizophrenia is particularly disabling and associated with an increased risk for substance use disorders. Antipsychotic medications can be effective, but persistent “negative” symptoms warrant comprehensive, supportive approaches with sufficient ancillary services. Those with personality disorders have high rates of substance use disorders and can be a challenge to treat. A strong team-based approach, psychosocial treatments, and sometimes medications can improve outcomes. Those with attention-deficit/hyperactivity disorder are at increased risk for substance use disorders. Impairing symptoms of inattention and impulsivity may persist into adulthood, complicating substance use disorder treatment engagement and outcomes. Medications can be helpful, but care must be taken when considering prescribing stimulants.
APA, Harvard, Vancouver, ISO, and other styles
7

Daley, Dennis C., and Antoine Douaihy. "Managing a Co-occurring Psychiatric Disorder." In Managing Your Substance Use Disorder, edited by Dennis C. Daley and Antoine Douaihy, 159–68. Oxford University Press, 2019. http://dx.doi.org/10.1093/med-psych/9780190926670.003.0020.

Full text
Abstract:
The term “co-occurring disorders” refers to the presence of a psychiatric disorder and a substance use disorder. A psychiatric disorder increases the risk of a substance use disorder and vice versa. Treating one disorder improves the outcomes in treating the other. Psychiatric medications can be both effective and appropriate in treating the psychiatric disorder in people with co-occurring disorders. Medication-assisted treatment (MAT) can treat effectively the substance use disorder in people with co-occurring disorders. The goals of this chapter are to learn about the different types of psychiatric disorders, to learn about the causes of psychiatric disorders, and to assess the client’s psychiatric symptoms, if applicable.
APA, Harvard, Vancouver, ISO, and other styles
8

Daley, Dennis C., and Antoine Douaihy. "Psychiatric Illness Co-occurring with a Substance Use Problem." In A Family Guide to Coping with Substance Use Disorders, edited by Dennis C. Daley and Antoine Douaihy, 67–71. Oxford University Press, 2019. http://dx.doi.org/10.1093/med-psych/9780190926632.003.0008.

Full text
Abstract:
The combination of an SUD and a psychiatric disorder is called dual or co-occurring disorders (CODs). Rates of SUDs are especially high among individuals with antisocial or borderline personality disorders, bipolar illness, and schizophrenia. Having one disorder raises the risk of having the other. Psychiatric illness can affect how quickly a substance problem develops and response to treatment. It can also affect relapse to substance use. The effects of alcohol or other drugs can cause or worsen psychiatric symptoms. Suggestions are given for handling psychiatric emergencies, including suicide threats. An overview of the treatment options for patients with dual disorders is given.
APA, Harvard, Vancouver, ISO, and other styles
9

Painter, Kirstin, and Maria Scannapieco. "Substance Abuse Co-Occurrence with Mental Health Issues." In Understanding the Mental Health Problems of Children and Adolescents, 262–83. Oxford University Press, 2021. http://dx.doi.org/10.1093/oso/9780190927844.003.0017.

Full text
Abstract:
Substance abuse, including the use of alcohol and other drugs, is one of the most prevalent disorders among adolescents and young adults, co-occurring with many other psychiatric and mental health disorders. Some use of alcohol and drugs can be expected during adolescence; however, it is necessary to use screening tools to differentiate between misuse of drugs and alcohol and substance abuse. Some brief and comprehensive screening instruments are mentioned in this chapter for future reference. General indicators of substance abuse disorders such as physical and emotional symptoms, family issues, and social problems are explored, and the chapter discusses some of the most commonly abused drugs. Emphasis is put on incorporating treatments of substance abuse with treatments of mental illness for a more comprehensive intervention strategy for people with co-occurring disorders.
APA, Harvard, Vancouver, ISO, and other styles
10

Simonoff, Emily. "Management and treatment of autism spectrum disorders." In New Oxford Textbook of Psychiatry, edited by John R. Geddes, Nancy C. Andreasen, and Guy M. Goodwin, 289–98. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198713005.003.0030.

Full text
Abstract:
Autism spectrum disorder (ASD) is a chronic disorder beginning early in development and comprising lifelong impairments in social communication and restricted and repetitive behaviours and interests. The manifestations of these core symptoms frequently vary across individuals, especially with differences in intellectual ability, and may change with age. In addition, people with ASD have high rates of co-occurring psychiatric disorders, including attention-deficit/hyperactivity disorder, anxiety and depression, tics/Tourette’s syndrome, and sleep problems. They frequently exhibit behaviours that challenge others, including aggression, self-injury, and high levels of irritability. Hence, their treatment and management requires a comprehensive approach to core and co-occurring symptoms. Management should include evidence-based approaches from health and also ASD-specific support from education, employment, social care, and the wider community. There is insufficient evidence to guide best practice, and more research on interventions is urgently required.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Co-occurring symptoms"

1

How effective is medication for ADHD symptoms in children with ASD? ACAMH, December 2020. http://dx.doi.org/10.13056/acamh.14221.

Full text
Abstract:
Clinically significant attention-deficit/hyperactivity disorder (ADHD) symptoms are common and impairing in children with autism spectrum disorder (ASD).1 Moreover, ADHD is the most common co-occurring mental health diagnosis driving increased rates of medication use in children with ASD.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Co-occurring symptoms' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography